The Federal Laboratory Consortium is recognizing the U.S. Department of Energy?s Pacific Northwest National Laboratory (PNNL) (Richland, Washington) for bringing a laboratory-developed technology that improves research sample analysis to the marketplace.
The Federal Laboratory Consortium is recognizing the U.S. Department of Energy’s Pacific Northwest National Laboratory (PNNL) (Richland, Washington) for bringing a laboratory-developed technology that improves research sample analysis to the marketplace. The consortium is a nationwide network that encouraged federal laboratories to transfer the technologies they developed to commercial markets.
PNNL scientists developed a new way to manufacture emitters that are used by Michrom Bioresources, Inc. (Auburn, California). Traditionally, the tapered ends of emitters are made by heating a glass capillary and pulling until the end forms a fine tip. But this method can also make the capillary’s narrow opening even smaller at the tip. This often causes particles to get stuck in the tip, which produces unreliable readings and costly instrument downtime. PNNL’s process forms the tapered end by etching capillary tubes in a hydrofluoric acid solution. The method consistently creates an external taper without changing the capillary’s internal diameter, which allows emitters to spray aerosols at extremely low, controlled rates without clogging.
Mass spectrometer instruments equipped with the improved emitters can advance research related to human health, the environment, petrochemicals, drug development, and more.
PNNL licensed the patents behind the technique to Michrom just months after helping the company evaluate the new tips. Michrom began selling the new emitters as part of its CaptiveSpray ion source in October 2010. Six months later, Michrom was acquired by Bruker Corporation (Billerica, Massachusetts).
PNNL will receive the 2012 for Excellence in Technology Transfer award on May 3 at the consortium’s annual meeting in Pittsburgh, Pennsylvania. PNNL has been honored by the FLC more than any other federal laboratory with this award, collecting 75 awards since the program began in 1984.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.